Drug recall D-0006-2017
Product
Vyvanse (lisdexamfetamine dimesylate) Capsules 30 mg, 100 count bottle, Rx Only, Manufactured for: Shire US, Inc., Lexington, MA 02421, NDC 59417-103-10
Reason for recall
Presence of Foreign Tablets/Capsules
Lots and codes
Lot # AF3360B; Exp. 04/19
Recall details
- Recalling firm
- Shire, Chesterbrook, PA
- Quantity
- 7,680 bottles (768,000 capsules)
- Distribution
- Nationwide
- Type
- Voluntary: Firm initiated
- Recall initiated
- September 2, 2016
- Terminated
- March 8, 2019
Related products
- Vyvanse – drug information
- NDC 59417-117 Vyvanse · Lisdexamfetamine Dimesylate 30 mg/1 · Takeda Pharmaceuticals America, Inc.
- NDC 59417-118 Vyvanse · Lisdexamfetamine Dimesylate 40 mg/1 · Takeda Pharmaceuticals America, Inc.
- NDC 59417-119 Vyvanse · Lisdexamfetamine Dimesylate 50 mg/1 · Takeda Pharmaceuticals America, Inc.
- NDC 59417-115 Vyvanse · Lisdexamfetamine Dimesylate 10 mg/1 · Takeda Pharmaceuticals America, Inc.
- NDC 59417-103 Vyvanse · Lisdexamfetamine Dimesylate 30 mg/1 · Takeda Pharmaceuticals America, Inc.
- NDC 59417-120 Vyvanse · Lisdexamfetamine Dimesylate 60 mg/1 · Takeda Pharmaceuticals America, Inc.
- NDC 59417-104 Vyvanse · Lisdexamfetamine Dimesylate 40 mg/1 · Takeda Pharmaceuticals America, Inc.
- NDC 59417-106 Vyvanse · Lisdexamfetamine Dimesylate 60 mg/1 · Takeda Pharmaceuticals America, Inc.
- NDC 59417-107 Vyvanse · Lisdexamfetamine Dimesylate 70 mg/1 · Takeda Pharmaceuticals America, Inc.
- NDC 59417-101 Vyvanse · Lisdexamfetamine Dimesylate 10 mg/1 · Takeda Pharmaceuticals America, Inc.
- NDC 59417-116 Vyvanse · Lisdexamfetamine Dimesylate 20 mg/1 · Takeda Pharmaceuticals America, Inc.
- NDC 59417-105 Vyvanse · Lisdexamfetamine Dimesylate 50 mg/1 · Takeda Pharmaceuticals America, Inc.
- NDC 59417-102 Vyvanse · Lisdexamfetamine Dimesylate 20 mg/1 · Takeda Pharmaceuticals America, Inc.